DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Reiberger T, Ferlitsch A, Payer BA. et al; Vienna Hepatic Hemodynamic Lab.
Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis.
J Hepatol 2013;
58 (05) 911-921
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.